Antidotes Market Report 2024: Strategies And Recent Developments | Pfizer Inc., Johnson & Johnson, Merck & Co., Bayer AG, Novartis AG, Bristol Myers Squibb

The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033

The Business Research Company offers in-depth market insights through Antidotes Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.

Market Size And Growth Forecast:
The antidotes market size has grown strongly in recent years. It will grow from $2.04 billion in 2023 to $2.23 billion in 2024 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to poison control centers, regulatory approvals, industrial and occupational safety, education and training.

The antidotes market size is expected to see strong growth in the next few years. It will grow to $3.27 billion in 2028 at a compound annual growth rate (CAGR) of 10.0%. The growth in the forecast period can be attributed to drug overdose crisis, emerging toxins, regulatory support, telemedicine and remote consultation. Major trends in the forecast period include combination antidotes, personalized poison management, digital poison control, pediatric antidotes.

Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=13029&type=smp

Market Segmentation:
The main types of antidotes are chemical antidotes, physical antidotes, pharmacological antidotes and others. Chemical antidotes are substances or compounds specifically designed to counteract the toxic effects of certain chemical substances or poisons. They are used in situations where exposure to a harmful substance has occurred and their purpose is to neutralize, mitigate, or reverse the toxic effects. They are administered as injectable, oral, capsules, tablets and syrup for various applications such as animal bites and heavy metal poisoning. These are administrated by hospitals, homecare, specialty clinics and others.

Major Driver - Rising Poison Incidents Fuel Expansion Of The Antidotes Market
An increase in poison incidents is expected to propel the growth of the antidotes market going forward. Poison incidents refer to situations where individuals are exposed to, ingest, or come into contact with harmful or toxic substances to their health. Antidotes are critical in poisoning occurrences due to their counteract effects of dangerous substances. The antidote neutralizes, attenuates, or reverses the poison's damaging effects. For instance, in August 2022, according to a report published by The Office for National Statistics, a UK-based government department, in England and Wales, 4,859 drug poisoning-related fatalities were reported in 2021, translating to an annual mortality rate of 84.4 per million inhabitants, an increase of 6.2% from the rate of 79.5 per million in 2020. Therefore, an increase in poison incidents is driving the growth of the antidotes market.

Competitive Landscape:
Major players in the antidotes market are Pfizer Inc., Johnson & Johnson, Merck & Co., Bayer AG, Novartis AG, Bristol Myers Squibb, Alexion Pharmaceuticals Inc., AstraZeneca PLC, Sanofi S.A., Eli Lilly and Company, Boehringer Ingelheim International GmbH, Baxter International Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., CSL Behring, Daiichi Sanko Inc., Fresenius Kabi AG, Aurobindo Pharma Limited, Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals PLC, Ferring B.V., Lupin Limited, Zydus Lifesciences Ltd., Mallinckrodt Pharmaceuticals Ltd., Nichi-Iko Pharmaceutical Co. Ltd., Akorn Incorporated, Meridian Medical Technologies Inc., Alvogen Pharma India Pvt. Ltd., Wockhardt Limited, ADAPT Pharma Inc.

Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/antidotes-global-market-report

Top Trend - Leading Market Players Innovate With Atropine Sulfate Injections To Enhance Treatment Options In The Antidotes Market
Major market players are concentrating on creating innovative products, such as atropine sulfate injections, to alleviate their market reach and provide better treatment options. Atropine sulfate injection is an antimuscarinic medication that works by inhibiting the action of acetylcholine at parasympathetic nervous system muscarinic receptors. For instance, in August 2022, American Regent Inc., a US-based pharmaceutical company engaged in sterile injectables for healthcare providers, launched an atropine sulfate injection, USP, a traditional injectable drug used as an antisialagogue, an antidote for organophosphorus poisoning or muscarinic mushroom poisoning and to treat bradyasystolic cardiac arrest. It is intended for the temporary blockage of severe or life-threatening muscarinic effects.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Antidotes Market Characteristics
3. Antidotes Market Trends And Strategies
4. Antidotes Market - Macro Economic Scenario
5. Antidotes Market Size And Growth
…..
27. Antidotes Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

This release was published on openPR.